UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 95

Sortiert nach

Anlotinib optimizes anti-tumor innate immunity to potentiate the therapeutic effect of PD-1 blockade in lung cancer

Cancer Immunology, Immunotherapy, 2020-12, Vol.69 (12), p.2523-2532

2020

Link zum Volltext

Verfügbarkeit prüfen

Effect of Wellness Education on Quality of Life of Patients With Non–Small Cell Lung Cancer Treated With First-Line Icotinib and on Their Family Caregivers

Integrative cancer therapies, 2019-04, Vol.18, p.1534735419842373-1534735419842373

2019

Link zum Volltext

Verfügbarkeit prüfen

Apatinib prevents natural killer cell dysfunction to enhance the efficacy of anti-PD-1 immunotherapy in hepatocellular carcinoma

Cancer gene therapy, 2021-02, Vol.28 (1-2), p.89-97

2021

Link zum Volltext

Verfügbarkeit prüfen

Progression-Free Survival and Time to Progression as Real Surrogate End Points for Overall Survival in Advanced Breast Cancer: A Meta-Analysis of 37 Trials

Clinical breast cancer, 2018-02, Vol.18 (1), p.63-70

2018

Link zum Volltext

Verfügbarkeit prüfen

Real-world validation of the chemotherapy-induced nausea and vomiting predictive model and its optimization for identifying high-risk Chinese patients

Chinese medical journal, 2023-06, Vol.136 (11), p.1370-1372

2023

Link zum Volltext

Verfügbarkeit prüfen

Clinicopathological characteristics, staging classification, and survival outcomes of primary malignant melanoma of the esophagus

Journal of surgical oncology, 2018-03, Vol.117 (4), p.588-596

2018

Link zum Volltext

Verfügbarkeit prüfen

Nomogram based on multiparametric analysis of early‐stage breast cancer: Prediction of high burden metastatic axillary lymph nodes

Thoracic cancer, 2023-12, Vol.14 (35), p.3465-3474

2023

Link zum Volltext

Verfügbarkeit prüfen

Epifriedelinol Ameliorates DMBA-Induced Breast Cancer in Albino Rats by Regulating the PI3K/AKT Pathway

The Tohoku Journal of Experimental Medicine, 2022, Vol.257(4), pp.283-289

2022

Link zum Volltext

Verfügbarkeit prüfen

Optimal therapy for concomitant EGFR and TP53 mutated non-small cell lung cancer: a real-world study

BMC cancer, 2023-03, Vol.23 (1), p.198-198, Article 198

2023

Link zum Volltext

Verfügbarkeit prüfen

Clinicopathological Features, Staging Classification, and Clinical Outcomes of Esophageal Melanoma: Evaluation of a Pooled Case Series

Frontiers in oncology, 2022-07, Vol.12, p.858145-858145

2022

Link zum Volltext

Verfügbarkeit prüfen

Quercetin: A promising drug candidate against the potential SARS-CoV-2-Spike mutants with high viral infectivity

Computational and structural biotechnology journal, 2023-01, Vol.21, p.5092-5098

2023

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of Traditional Chinese Medicine in Treatment and Prophylaxis of Radiation-Induced Oral Mucositis in Patients Receiving Radiotherapy: A Randomized Controlled Trial

Integrative cancer therapies, 2018-06, Vol.17 (2), p.444-450

2018

Link zum Volltext

Verfügbarkeit prüfen

Baicalin reverses radioresistance in nasopharyngeal carcinoma by downregulating autophagy

Cancer cell international, 2020-01, Vol.20 (1), p.35-8, Article 35

2020

Link zum Volltext

Verfügbarkeit prüfen

Traditional Chinese medicine formula 01 for nasopharyngeal carcinoma (NPC01) for head & neck cancer and health-related quality of life: a retrospective study

BMC complementary medicine and therapies, 2022-08, Vol.22 (1), p.216-216, Article 216

2022

Link zum Volltext

Verfügbarkeit prüfen

Icotinib alone or with bevacizumab as first‐line therapy in Chinese patients with advanced nonsquamous non‐small cell lung cancer and activating EGFR mutations: A retrospective study

Thoracic cancer, 2021-09, Vol.12 (17), p.2369-2374

2021

Link zum Volltext

Verfügbarkeit prüfen

Influence of wellness education on first-line icotinib hydrochloride patients with stage IV non–small cell lung cancer and their family caregivers

Current problems in cancer, 2018-05, Vol.42 (3), p.358-366

2018

Link zum Volltext

Verfügbarkeit prüfen

Progress of PD-1/PD-L1 Inhibitors in Non-small Cell Lung Cancer

Zhongguo fei ai za zhi, 2017-02, Vol.20 (2)

2017

Link zum Volltext

Verfügbarkeit prüfen

Camrelizumab in Combination with Apatinib in Patients with Advanced Hepatocellular Carcinoma (RESCUE): A Nonrandomized, Open-label, Phase II Trial

Clinical cancer research, 2021-02, Vol.27 (4), p.1003-1011

2021

Link zum Volltext

Verfügbarkeit prüfen

Progress of PD-1/PD-L1 Inhibitors in Non-small Cell Lung Cancer

Zhongguo fei ai za zhi, 2017-02, Vol.20 (2), p.138-142

2017

Link zum Volltext

Verfügbarkeit prüfen

Effect of traditional Chinese medicine on pyrotinib-associated diarrhea in patients with HER2-positive breast cancer

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e24096-e24096

2022

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of lapatinib versus trastuzumab in neoadjuvant therapy of HER-2 positive breast cancer: a meta-analysis

Zhong hua yi xue za zhi, 2014-12, Vol.94 (48), p.3854-3858

2014

Link zum Volltext

Verfügbarkeit prüfen

Ginsenoside Rg3 attenuates cisplatin resistance in lung cancer by downregulating PD-L1 and resuming immune

Biomedicine & pharmacotherapy, 2017-12, Vol.96, p.378-383

2017

Link zum Volltext

Verfügbarkeit prüfen

Oxymatrine Inhibits Development of Morphine-Induced Tolerance Associated With Decreased Expression of P-glycoprotein in Rats

Integrative cancer therapies, 2010-06, Vol.9 (2), p.213-218

2010

Link zum Volltext

Verfügbarkeit prüfen

Effect of bevacizumab plus double dose icotinib on advanced non-small cell lung cancer with EGFR L858R mutation

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e21020-e21020

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 95

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(87)
Mit Volltextzugriff
(92)

Publikationsform

Artikel
(83)
Buchkapitel
(12)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(75)
Life Sciences & Biomedicine
(55)
Humans
(30)
Oncology
(27)
Technology
(18)
Female
(15)
Apoptosis
(14)
Male
(13)
Cancer Therapies
(12)
Chemotherapy
(12)
Computer Science
(12)
Computer Science, Artificial Intelligence
(12)
Computer Science, Theory & Methods
(12)
Metastasis
(12)
Patients
(12)
Animals
(10)
Medical Prognosis
(10)
Cancer
(9)
Middle Aged
(9)
Breast Cancer
(8)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Anlotinib optimizes anti-tumor innate immunity to potentiate the therapeutic effect of PD-1 blockade in lung cancer

Effect of Wellness Education on Quality of Life of Patients With Non–Small Cell Lung Cancer Treated With First-Line Icotinib and on Their Family Caregivers

Apatinib prevents natural killer cell dysfunction to enhance the efficacy of anti-PD-1 immunotherapy in hepatocellular carcinoma

Progression-Free Survival and Time to Progression as Real Surrogate End Points for Overall Survival in Advanced Breast Cancer: A Meta-Analysis of 37 Trials

Real-world validation of the chemotherapy-induced nausea and vomiting predictive model and its optimization for identifying high-risk Chinese patients

Clinicopathological characteristics, staging classification, and survival outcomes of primary malignant melanoma of the esophagus

Nomogram based on multiparametric analysis of early‐stage breast cancer: Prediction of high burden metastatic axillary lymph nodes

Epifriedelinol Ameliorates DMBA-Induced Breast Cancer in Albino Rats by Regulating the PI3K/AKT Pathway

Optimal therapy for concomitant EGFR and TP53 mutated non-small cell lung cancer: a real-world study

Clinicopathological Features, Staging Classification, and Clinical Outcomes of Esophageal Melanoma: Evaluation of a Pooled Case Series

Quercetin: A promising drug candidate against the potential SARS-CoV-2-Spike mutants with high viral infectivity

Efficacy of Traditional Chinese Medicine in Treatment and Prophylaxis of Radiation-Induced Oral Mucositis in Patients Receiving Radiotherapy: A Randomized Controlled Trial

Baicalin reverses radioresistance in nasopharyngeal carcinoma by downregulating autophagy

Traditional Chinese medicine formula 01 for nasopharyngeal carcinoma (NPC01) for head & neck cancer and health-related quality of life: a retrospective study

Icotinib alone or with bevacizumab as first‐line therapy in Chinese patients with advanced nonsquamous non‐small cell lung cancer and activating EGFR mutations: A retrospective study

Influence of wellness education on first-line icotinib hydrochloride patients with stage IV non–small cell lung cancer and their family caregivers

Progress of PD-1/PD-L1 Inhibitors in Non-small Cell Lung Cancer

Camrelizumab in Combination with Apatinib in Patients with Advanced Hepatocellular Carcinoma (RESCUE): A Nonrandomized, Open-label, Phase II Trial

Progress of PD-1/PD-L1 Inhibitors in Non-small Cell Lung Cancer

Effect of traditional Chinese medicine on pyrotinib-associated diarrhea in patients with HER2-positive breast cancer

Efficacy of lapatinib versus trastuzumab in neoadjuvant therapy of HER-2 positive breast cancer: a meta-analysis

Ginsenoside Rg3 attenuates cisplatin resistance in lung cancer by downregulating PD-L1 and resuming immune

Sintilimab versus placebo in combination with chemotherapy as first line treatment for locally advanced or metastatic oesophageal squamous cell carcinoma (ORIENT-15): multicentre, randomised, double blind, phase 3 trial

Oxymatrine Inhibits Development of Morphine-Induced Tolerance Associated With Decreased Expression of P-glycoprotein in Rats

Effect of bevacizumab plus double dose icotinib on advanced non-small cell lung cancer with EGFR L858R mutation

Suchergebnisse filtern